Information Provided By:
Fly News Breaks for February 20, 2019
Feb 20, 2019 | 07:14 EDT
SunTrust analyst David MacDonald lowered his price target on Tivity Health (TVTY) to $28 to reflect the lower FY19 guidance that accompanied an otherwise solid Q4 report. The analyst keeps his Buy rating on the shares however and further notes that there are potential benefits coming from the pending Nutrisystem (NTRI) deal, with added positives out of the company's recent Walmart (WMT) agreement and its "cap-ex light model".